MAI Capital Management’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11M Buy
105,938
+4,044
+4% +$361K 0.04% 321
2026
Q1
$7.32M Sell
101,894
-3,425
-3% -$264K 0.04% 336
2025
Q4
$8.36M Buy
105,319
+27,985
+36% +$2.21M 0.05% 308
2025
Q3
$5.83M Buy
77,334
+31,217
+68% +$2.14M 0.04% 331
2025
Q2
$3.18M Sell
46,117
-373
-0.8% -$24.5K 0.02% 409
2025
Q1
$3.15M Sell
46,490
-5,280
-10% -$316K 0.02% 395
2024
Q4
$2.32M Sell
51,770
-3,384
-6% -$190K 0.02% 456
2024
Q3
$3.47M Sell
55,154
-16,051
-23% -$936K 0.03% 306
2024
Q2
$4.21M Sell
71,205
-29,436
-29% -$1.84M 0.04% 285
2024
Q1
$8.03M Buy
100,641
+3,697
+4% +$282K 0.08% 194
2023
Q4
$7.65M Sell
96,944
-3,223
-3% -$229K 0.1% 162
2023
Q3
$6.99M Sell
100,167
-2,669
-3% -$189K 0.1% 168
2023
Q2
$7.11M Buy
102,836
+7,985
+8% +$568K 0.1% 168
2023
Q1
$7.05M Sell
94,851
-3,715
-4% -$312K 0.11% 162
2022
Q4
$9.19M Buy
98,566
+4,015
+4% +$387K 0.15% 126
2022
Q3
$9.02M Buy
94,551
+25,804
+38% +$2.55M 0.17% 123
2022
Q2
$6.37M Sell
68,747
-1,962
-3% -$191K 0.12% 142
2022
Q1
$7.16M Sell
70,709
-198,792
-74% -$20.9M 0.12% 141
2021
Q4
$27.8M Sell
269,501
-1,743
-0.6% -$161K 0.45% 58
2021
Q3
$23M Buy
271,244
+31,741
+13% +$2.66M 0.44% 62
2021
Q2
$20M Buy
239,503
+10,136
+4% +$830K 0.4% 65
2021
Q1
$17.3M Buy
229,367
+145,824
+175% +$10.6M 0.39% 67
2020
Q4
$5.71M Sell
83,543
-100,992
-55% -$6.57M 0.14% 124
2020
Q3
$10.8M Buy
184,535
+2,787
+2% +$173K 0.31% 81
2020
Q2
$11.8M Buy
181,748
+6,533
+4% +$411K 0.37% 64
2020
Q1
$10.4M Buy
175,215
+23,548
+16% +$1.57M 0.42% 58
2019
Q4
$11.3M Buy
151,667
+8,793
+6% +$617K 0.37% 65
2019
Q3
$9.01M Sell
142,874
-4,079
-3% -$242K 0.4% 66
2019
Q2
$8.01M Buy
146,953
+39,840
+37% +$2.15M 0.36% 74
2019
Q1
$5.78M Buy
107,113
+13,125
+14% +$810K 0.3% 93
2018
Q4
$6.16M Buy
93,988
+4,355
+5% +$325K 0.36% 80
2018
Q3
$7.06M Buy
89,633
+2,145
+2% +$153K 0.36% 84
2018
Q2
$5.63M Buy
87,488
+1,464
+2% +$96.5K 0.3% 95
2018
Q1
$5.35M Sell
86,024
-6,900
-7% -$495K 0.3% 94
2017
Q4
$6.74M Sell
92,924
-4,801
-5% -$349K 0.38% 80
2017
Q3
$7.95M Buy
97,725
+2,979
+3% +$236K 0.48% 64
2017
Q2
$7.62M Sell
94,746
-1,815
-2% -$143K 0.49% 60
2017
Q1
$7.58M Sell
96,561
-2,784
-3% -$222K 0.51% 57
2016
Q4
$7.84M Buy
99,345
+5,773
+6% +$467K 0.57% 56
2016
Q3
$8.33M Sell
93,572
-946
-1% -$89.3K 0.63% 53
2016
Q2
$9.05M Sell
94,518
-783
-0.8% -$78K 0.7% 47
2016
Q1
$9.89M Buy
95,301
+236
+0.2% +$22.9K 0.76% 39
2015
Q4
$9.29M Buy
95,065
+75,849
+395% +$7.43M 0.71% 45
2015
Q3
$1.85M Sell
19,216
-3,143
-14% -$330K 0.14% 143
2015
Q2
$2.35M Buy
22,359
+4,834
+28% +$494K 0.15% 135
2015
Q1
$1.81M Buy
17,525
+9,500
+118% +$961K 0.12% 151
2014
Q4
$773K Buy
8,025
+169
+2% +$14.9K 0.05% 234
2014
Q3
$625K Hold
7,856
0.06% 220
2014
Q2
$592K Sell
7,856
-533
-6% -$40.3K 0.06% 215
2014
Q1
$628K Sell
8,389
-33,884
-80% -$2.39M 0.06% 196
2013
Q4
$3.02M Sell
42,273
-3,035
-7% -$195K 0.32% 79
2013
Q3
$2.57M Buy
45,308
+1,290
+3% +$76.9K 0.33% 67
2013
Q2
$2.52M Buy
+44,018
New +$2.55M 0.33% 68

Other funds holding CVS

MAI Capital Management's CVS Position: Q2 2026 in Review

MAI Capital Management increased its CVS Health (CVS) stake by 4% in Q2 2026, buying an estimated $361K and bringing the position to 105,938 shares worth $11M. The position accounts for 0.04% of the portfolio, ranked #321.

MAI Capital Management first reported a position in CVS in Q2 2013 and has held it in 53 quarters since. The position peaked at $27.8M in Q4 2021. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • MAI Capital Management held 105,938 shares of CVS Health worth $11M as of Q2 2026.
  • MAI Capital Management bought 4,044 CVS Health shares in Q2 2026, an estimated $361K.
  • CVS Health made up 0.04% of MAI Capital Management's portfolio in Q2 2026, its #321 holding.
  • MAI Capital Management first reported a position in CVS Health in Q2 2013 and has held it in 53 quarters since.
  • MAI Capital Management's CVS Health position peaked at $27.8M in Q4 2021.
  • 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on MAI Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.